Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
14 Nov 2018 FDA Grants Accelerated Approval to Pembrolizumab for Hepatocellular Carcinoma Gastrointestinal cancers - Cancer Immunology and Immunotherapy
13 Nov 2018 ESMO Releases New Patient Guide in Prostate Cancer Genitourinary cancers
12 Nov 2018 Latest European Commission Initiative on Breast Cancer Recommendations Breast cancer
09 Nov 2018 Radiotherapy-induced Responses Enhance the Efficacy of Anti-CTLA4 Therapy in Chemo-refractory Metastatic NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
08 Nov 2018 EMA’s Regulatory Science Strategy to 2025 Bioethics, legal and economic issues
07 Nov 2018 Improving Availability of Medicines in the EU Bioethics, legal and economic issues
06 Nov 2018 FDA Approves Lorlatinib for Second- or Third-line Treatment of ALK-positive Metastatic NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
02 Nov 2018 FDA Approves Pembrolizumab in Combination with Chemotherapy for First-line Treatment of Metastatic Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
31 Oct 2018 Molecular Diagnostic Programme for Better Cancer Treatment Kicks Off in Luxembourg Personalised medicine
30 Oct 2018 Patient-derived Paediatric Brain Tumour Models Central nervous system malignancies - Translational research
29 Oct 2018 Biosimilar Medicine Ogivri (Trastuzumab) Received a Positive Opinion from the EMA CHMP Breast cancer - Gastrointestinal cancers - Anticancer agents & Biologic therapy
26 Oct 2018 FDA Approves Talazoparib for gBRCAm HER2-negative Locally Advanced or Metastatic Breast Cancer Breast cancer - Personalised medicine - Anticancer agents & Biologic therapy
25 Oct 2018 EMA Recommends Pembrolizumab for the Adjuvant Treatment of Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
24 Oct 2018 Capmatinib Is Highly Active in Patients with Met∆ex14-Mutated NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
24 Oct 2018 Carboplatin Plus Paclitaxel Respresents a New Standard of Care for Patients with Squamous Cell Carcinoma of the Anal Canal Gastrointestinal cancers - Anticancer agents & Biologic therapy